Position in BNTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,676
+$255 QoQ
Shares Held
61
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#248
of 282 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TrinityBridge Ltd holds $959,256 across 12 Biotechnology names. BNTX ranks #9 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
19,000 | $498,180 | |
| 2 | IMCR |
Immunocore Holdings plc
|
10,100 | $320,675 | |
| 3 | ORMP |
Oramed Pharmaceuticals Inc.
|
11,675 | $56,156 | |
| 4 | ABSI |
Absci Corp
|
2,555 | $29,612 | |
| 5 | CADL |
Candel Therapeutics, Inc.
|
1,350 | $13,905 | |
| 6 | INCY |
Incyte Corp
|
120 | $13,603 | |
| 7 | AUTL |
Autolus Therapeutics plc
|
6,300 | $10,080 | |
| 8 | ATYR |
aTYR PHARMA INC
|
12,300 | $7,343 |
All Filings in BNTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,676 | 61 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $5,421 | 61 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,807 | 61 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $6,015 | 61 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||